Computer‐based multimodal training module facilitates standardization of the technique of complete mesocolic excision for right‐sided colon cancer. Long‐term oncological outcomes are good.

2021 ◽  
Author(s):  
Burak Kutlu ◽  
Cigdem Benlice ◽  
Firat Kocaay ◽  
Yigit Gungor ◽  
Erkin Ismail ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Complete Mesocolic Excision ◽  
Training Module ◽  
Oncological Outcomes ◽  
Mesocolic Excision ◽  
Computer Based ◽  
Multimodal Training

Oncological outcomes after complete mesocolic excision in right‐sided colon cancer: a population‐based study

2021 ◽  
Author(s):  
Richard Bernhoff ◽  
Annika Sjövall ◽  
Fredrik Granath ◽  
Torbjörn Holm ◽  
Anna Martling ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Complete Mesocolic Excision ◽  
Population Based ◽  
Population Based Study ◽  
Oncological Outcomes ◽  
Mesocolic Excision

scholarly journals Robotic Complete Mesocolic Excision with Central Vascular Ligation for Right Colon Cancer: Surgical Technique and Short-term Outcomes

2020 ◽  
Vol 11 (4) ◽  
pp. 674-683
Author(s):  
C. Ramachandra ◽  
Pavan Sugoor ◽  
Uday Karjol ◽  
Ravi Arjunan ◽  
Syed Altaf ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Open Surgery ◽  
Complete Mesocolic Excision ◽  
Right Colon ◽  
Short Term ◽  
Central Vascular Ligation ◽  
Oncological Outcomes ◽  
Right Colon Cancer ◽  
Vascular Ligation ◽  
Mesocolic Excision

Abstract Background Minimally invasive colorectal surgery has demonstrated to have the same oncological results as open surgery, with better clinical outcomes. Robotic assistance is an evolution of minimally invasive technique. Purpose The study aims to present technical details and short-term oncological outcomes of robotic-assisted complete mesocolic excision (CME) with central vascular ligation (CVL) for right colon cancer. Methodology Fifty-two consecutive patients affected by right colon cancer were operated between May 2016 and February 2020 with da Vinci Xi platform. Data regarding surgical and short-term oncological outcomes were systematically collected in a colorectal specific database for statistical analysis. Results Thirty-seven (71.15%) and 15 (28.85%) patients underwent right and extended right hemicoletomy with an extracorporeal anastomosis. Median age was 55 years. Mean operative time was 182 ± 36 min. Mean blood loss was 110 ± 90 ml. Conversion rate was 3.84% (two cases). 78.84% (41 cases) were pT3 and mean number of harvested lymph nodes was 28 ± 4. 1/52 (1.92%) had a documented anastomotic leak requiring exploratory laparotomy and diversion proximal ileostomy. Surgery-related grade IIIa–IIIb Calvien Dindo morbidity were noted in 9.61% and 1.92%, respectively. Conclusion Robotic assistance allows performance of oncological adequate dissection of the right colon with radical lymphadenectomy as in open surgery, confirming the safety and oncological adequacy of this technique, with acceptable results and short-term outcomes.

Long-term Outcomes of Single-Site Laparoscopic Colectomy With Complete Mesocolic Excision for Colon Cancer

2017 ◽  
Vol 60 (7) ◽  
pp. 664-673 ◽  
Author(s):  
Masaaki Miyo ◽  
Ichiro Takemasa ◽  
Hiroyuki Ishihara ◽  
Taishi Hata ◽  
Tsunekazu Mizushima ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Laparoscopic Colectomy ◽  
Complete Mesocolic Excision ◽  
Single Site ◽  
Long Term Outcomes ◽  
Mesocolic Excision

Long-term results following an anatomically based surgical technique for resection of colon cancer: a comparison with results from complete mesocolic excision

2016 ◽  
Vol 18 (7) ◽  
pp. 676-683 ◽  
Author(s):  
L. Bokey ◽  
P. H. Chapuis ◽  
C. Chan ◽  
P. Stewart ◽  
M. J. F. X. Rickard ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Surgical Technique ◽  
Complete Mesocolic Excision ◽  
Long Term Results ◽  
Mesocolic Excision

scholarly journals Long-term outcomes after complete mesocolic excision for colon cancer at a tertiary care center in Saudi Arabia

2020 ◽  
Vol 40 (3) ◽  
pp. 207-211
Author(s):  
Reem A. Alharbi ◽  
Riyadh Hakami ◽  
Khayal A. Alkhayal ◽  
Omar A. Al-Obeed ◽  
Thamer A. Bin Traiki ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Care Center ◽  
Tertiary Care ◽  
Disease Free Survival ◽  
Complete Mesocolic Excision ◽  
Recurrence Rates ◽  
Free Survival ◽  
Mesocolic Excision ◽  
Disease Free

ABSTRACT BACKGROUND: Data on long-term survival and recurrence of cancer after complete mesocolic excision (CME) for colon cancer has not been reported from our center and related to international data. OBJECTIVE: Describe overall and disease-free survival, survival by surgery site and stage, and recurrence rates after curative surgery. DESIGN: Retrospective chart review. SETTINGS: Academic tertiary care center. PATIENTS AND METHODS: The study included all patients who underwent either laparoscopic or open surgery for colon cancer with curative intent between 2001 and 2011. The colorectal database was reviewed for the following: demographic data, comorbidities, radiologic investigations, clinical stage, type of operation, complications, pathologic assessment, adjuvant treatment, recurrence and survival. Survival and recurrence rates were calculated, and survival curves were generated. MAIN OUTCOME MEASURES: 5-year overall survival, secondary endpoints were 5-year disease-free survival, survival by surgery site and stage, and recurrence rates. SAMPLE SIZE: 220. RESULTS: The mean (SD) age at diagnosis was 57 (13) years (CI 95%: 55-59 years). There were 112 males. Mean (SD) body mass index was 27.6 (5.7) kg/m 2 (CI 95%: 27-28). Pathological assessment revealed R0 (microscopically margin-negative) resection in 207 (94%). The overall 5-year survival and disease-free survival was 77.9% and 70%, respectively. The 5-year disease-free survival was 69% for the sigmoid/left colon and 69% for the right colon (difference statistically nonsignificant). Stages at the time of resection were stage 0 for 2 (0.01%) patients, stage I for 18 (8%), stage II for 92 (42%), stage III for 100 (46%), and stage IV for 6 (3%). The 5-year overall survival by stages I, II, III and IV was 94%, 80%, 75% and 50%, respectively (difference statistically non-significant). The overall 5-year recurrence rate was 23.4%. CONCLUSION: The outcomes of surgical treatment for colon cancer at our institution are equivalent to international sites. No difference was noted between left and right colon in terms of survival after CME. LIMITATIONS: Single center, retrospective, small sample size. CONFLICT OF INTEREST: None.

scholarly journals Laparoscopic complete mesocolic excision with central vascular ligation for splenic flexure colon cancer: short- and long-term outcomes

2021 ◽  
Author(s):  
Kazuki Ueda ◽  
Koji Daito ◽  
Hokuto Ushijima ◽  
Yoshinori Yane ◽  
Yasumasa Yoshioka ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Splenic Flexure ◽  
Complete Mesocolic Excision ◽  
Middle Colic Artery ◽  
Long Term Outcomes ◽  
Central Vascular Ligation ◽  
Vascular Ligation ◽  
Mesocolic Excision ◽  
Short And Long Term

Abstract Background Complete mesocolic excision (CME) with central vascular ligation (CVL) for colon cancer is an essential procedure for improved oncologic outcomes after surgery. Laparoscopic surgery for splenic flexure colon cancer was recently adopted due to a greater understanding of surgical anatomy and improvements in surgical techniques and innovative surgical devices. Methods We retrospectively analyzed the data of patients with splenic flexure colon cancer who underwent laparoscopic CME with CVL at our institution between January 2005 and December 2017. Results Forty-five patients (4.8%) were enrolled in this study. Laparoscopic CME with CVL was successfully performed in all patients. The median operative time was 178 min, and the median estimated blood loss was 20 g. Perioperative complications developed in 6 patients (13.3%). The median postoperative hospital stay was 9 days. According to the pathological report, the median number of harvested lymph nodes was 15, and lymph node metastasis developed in 14 patients (31.1%). No metastasis was observed at the root of the middle colic artery or the inferior mesenteric artery. The median follow-up period was 49 months. The cumulative 5-year overall survival and disease-free survival rates were 85.9% and 84.7%, respectively. The cancer-specific survival rate in stage I-III patients was 92.7%. Recurrence was observed in 5 patients (11.1%), including three patients with peritoneal dissemination and two patients with distant metastasis. Conclusions Laparoscopic CME with CVL for splenic flexure colon cancer appears to be oncologically safe and feasible based on the short- and long-term outcomes in our study. However, it is careful to introduce this procedure to necessitate the anatomical understandings and surgeon’s skill. The appropriate indications must be established with more case registries because our experience is limited.

Sign in / Sign up

Export Citation Format

Share Document